Literature DB >> 14748860

Relationship between conflicts of interest and research results.

Lee S Friedman1, Elihu D Richter.   

Abstract

CONTEXT: To date, research regarding the influence of conflicts of interest on the presentation of findings by researchers has been limited.
OBJECTIVE: To evaluate the sources of funding for published manuscripts, and association between reported findings and conflicts of interest.
METHODS: Data from both print and electronic issues of The New England Journal of Medicine (NEJM) and The Journal of the American Medical Association (JAMA) were analyzed for sources of funding, areas of investigation, conflict of interest (COI), and presentation of results. We reviewed all original manuscripts published during the year 2001 within NEJM (N = 193) and JAMA (N = 205). We use 3 definitions for COI in this paper: a broadly defined criterion, the criterion used by The International Council of Medical Journal Editors (ICMJE), and a criterion defined by the authors.
RESULTS: Depending on the COI criteria used, 16.6% to 32.6% of manuscripts had 1 or more author with COI. Based on ICMJE criterion, 38.7% of studies investigating drug treatments had authors with COI. We observed a strong association between those studies whose authors had COI and reported positive findings (P <.001). When controlling for sample size, study design, and country of primary authors, we observed a strong association between positive results and COI (ICMJE definition) among all treatment studies (adjusted odds ratio [OR], 2.35; 95% confidence interval [CI], 1.08 to 5.09) and drug studies alone (OR, 2.64; 95% CI, 1.09 to 6.39).
CONCLUSION: COI is widespread among the authors of published manuscripts and these authors are more likely to present positive findings.

Entities:  

Keywords:  Biomedical and Behavioral Research; Empirical Approach

Mesh:

Year:  2004        PMID: 14748860      PMCID: PMC1494677          DOI: 10.1111/j.1525-1497.2004.30617.x

Source DB:  PubMed          Journal:  J Gen Intern Med        ISSN: 0884-8734            Impact factor:   5.128


  15 in total

1.  Conflict of interest. NEJM admits breaking its own tough rules.

Authors:  C Holden
Journal:  Science       Date:  2000-03-03       Impact factor: 47.728

2.  Evaluation of conflict of interest in economic analyses of new drugs used in oncology.

Authors:  M Friedberg; B Saffran; T J Stinson; W Nelson; C L Bennett
Journal:  JAMA       Date:  1999-10-20       Impact factor: 56.272

3.  Conflicts of interest in biomedical research.

Authors:  D Korn
Journal:  JAMA       Date:  2000-11-01       Impact factor: 56.272

4.  Conflict of interest and the public trust.

Authors:  C D DeAngelis
Journal:  JAMA       Date:  2000-11-01       Impact factor: 56.272

5.  Assessing faculty financial relationships with industry: A case study.

Authors:  E A Boyd; L A Bero
Journal:  JAMA       Date:  2000-11-01       Impact factor: 56.272

6.  The association between funding by commercial interests and study outcome in randomized controlled drug trials.

Authors:  J Yaphe; R Edman; B Knishkowy; J Herman
Journal:  Fam Pract       Date:  2001-12       Impact factor: 2.267

7.  Protecting subjects, preserving trust, promoting progress I: policy and guidelines for the oversight of individual financial interests in human subjects research.

Authors: 
Journal:  Acad Med       Date:  2003-02       Impact factor: 6.893

8.  Source of funding and outcome of clinical trials.

Authors:  R A Davidson
Journal:  J Gen Intern Med       Date:  1986 May-Jun       Impact factor: 5.128

9.  Evaluation of HIV-1 immunogen, an immunologic modifier, administered to patients infected with HIV having 300 to 549 x 10(6)/L CD4 cell counts: A randomized controlled trial.

Authors:  J O Kahn; D W Cherng; K Mayer; H Murray; S Lagakos
Journal:  JAMA       Date:  2000-11-01       Impact factor: 56.272

10.  Funding source, trial outcome and reporting quality: are they related? Results of a pilot study.

Authors:  Tammy J Clifford; Nicholas J Barrowman; David Moher
Journal:  BMC Health Serv Res       Date:  2002-09-04       Impact factor: 2.655

View more
  51 in total

1.  Medical reversal: why we must raise the bar before adopting new technologies.

Authors:  Vinay Prasad; Adam Cifu
Journal:  Yale J Biol Med       Date:  2011-12

2.  Re-envisioning our approach to research in academia.

Authors:  Arthur M Feldman
Journal:  Clin Transl Sci       Date:  2008-12       Impact factor: 4.689

3.  The availability of references and the sponsorship of original research cited in pharmaceutical advertisements.

Authors:  Richelle J Cooper; David L Schriger
Journal:  CMAJ       Date:  2005-02-15       Impact factor: 8.262

4.  Fostering integrity in research: definitions, current knowledge, and future directions.

Authors:  Nicholas H Steneck
Journal:  Sci Eng Ethics       Date:  2006-01       Impact factor: 3.525

5.  The limits of disclosure: what research subjects want to know about investigator financial interests.

Authors:  Christine Grady; Elizabeth Horstmann; Jeffrey S Sussman; Sara Chandros Hull
Journal:  J Law Med Ethics       Date:  2006       Impact factor: 1.718

6.  Drug information education in doctor of pharmacy programs.

Authors:  Fei Wang; William G Troutman; Teresa Seo; Amy Peak; Jack M Rosenberg
Journal:  Am J Pharm Educ       Date:  2006-06-15       Impact factor: 2.047

7.  Transparency in economic evaluations.

Authors:  Suzanne Hill
Journal:  Pharmacoeconomics       Date:  2005       Impact factor: 4.981

8.  Conflict of Interest Disclosure Policies and Practices in Peer-reviewed Biomedical Journals.

Authors:  Richelle J Cooper; Malkeet Gupta; Michael S Wilkes; Jerome R Hoffman
Journal:  J Gen Intern Med       Date:  2006-12       Impact factor: 5.128

9.  Conflict of Interest and Funding Disclosure Policies of Environmental, Occupational, and Public Health Journals.

Authors:  David B Resnik; Brandon Konecny; Grace E Kissling
Journal:  J Occup Environ Med       Date:  2017-01       Impact factor: 2.162

10.  Relationships between authorship contributions and authors' industry financial ties among oncology clinical trials.

Authors:  Susannah L Rose; Monika K Krzyzanowska; Steven Joffe
Journal:  J Clin Oncol       Date:  2010-01-11       Impact factor: 44.544

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.